Teva Respiratory For Sale

Discussion in 'Teva Respiratory' started by anonymous, Aug 9, 2017 at 9:36 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Teva Pharmaceutical Industries Ltd (TEVA) is ramping up its asset sales in an effort to preserve its credit rating and cut its debt, Bloomberg reported.


    Moody's Corp (MCO) rates Israel-based generic drugmaker Teva "Baa3" with a negative outlook one step above junk. S&P Global (SPI) rates Teva the equivalent of one level higher at "BBB." Fitch Ratings puts Teva at "BBB-."


    Teva is said to be considering a disposal of its Icelandic unit Medis, valued between $500 million and $1 billion. Also on the table is Teva's respiratory treatments unit worth between $500 million and $2 billion. Teva hasn't made any concrete decisions and considerations are still in the early stages, insiders say
    Teva stock has borne the brunt of generic drug pricing pressure, falling over 40% since it reported disappointing second quarter earnings August 3. Teva stock traded up 0.44% to $18.37 Wednesday morning.
     

  2. anonymous

    anonymous Guest

    Use some common sense. Valuation way too low to be US.
     
  3. anonymous

    anonymous Guest

    Mgmnt already trying to "spin it". Love the transparency TR. Read last sentence..........deliberations are private. If anything, Biologics are the ones who are safe. Look how that team is treated (10,000.00 raises?) compared to our sales force. The sad thing about it is for those who are still at TR after the layoffs earlier this year will continue to put their heads in the sand. I along with many others got out of dodge months ago.

    BLOOMBERG
    Teva Ramps Up Sales With Medis, Respiratory Units
    The company is also weighing a sale of some of its respiratory treatment assets, the people said, asking not to be identified because deliberations are private.
     
  4. anonymous

    anonymous Guest

    So Carney i mean corny.
    Spoken like a true Fish.
     
  5. anonymous

    anonymous Guest

    Hey dipshit amateur wanna be financial analyst, how many Respiratory units does teva have?

    "Bloomberg News, citing people familiar with the matter, reported that Medis would be valued at $500 million to $1 billion. It said Teva may also sell its respiratory treatments unit for as much as $2 billion."
     
  6. anonymous

    anonymous Guest

    Thanks for the insight fishturd
     
  7. anonymous

    anonymous Guest

    How many oncology units does Teva have?
     
  8. anonymous

    anonymous Guest

    The same number as your IQ